We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Multifunctional Microplate Reader Now Available

By LabMedica International staff writers
Posted on 01 Sep 2010
Life science and biotech researchers now have available a state-of-the-art microplate reader with a wide range of capabilities from UV-Vis absorbance to bottom fluorescence and luminescence. More...


The BioTek Instruments, Inc. (Winooski, VT, USA) Synergy H1 Hybrid Multi-Mode Microplate Reader is a flexible monochromator-based multimode microplate reader. The monochromator optics uses a third generation quadruple-grating design that allows working at any excitation or emission wavelength with a one-nanometer step. This system supports top and bottom fluorescence intensity, UV-visible absorbance, and high-performance luminescence detection. It can handle all the standard microplate applications found in life science research laboratories.

A filter module is available as a completely independent add-on that includes its own light source, and a high performance dichroic-based wavelength selection system. With its very high optical efficiency, this module supports advanced detection modes such as Fluorescence Polarization, Time-Resolved Fluorescence and filtered luminescence (e.g.,  BRET).

A dual reagent injection system is available to automate inject/read assays such as ion channels assays or flash luminescence assays (e.g., luciferase or ATP assays). The Synergy H1 incorporates BioTek's Gen5 Data Analysis Software for advanced reader control, data analysis, graphing, exporting, and reporting. Additionally, Synergy H1 is compatible with BioTek's Take3 Multi-Volume Plate that measures up to 16 two-microliter samples, two BioCells or a standard cuvette for fast and simple multivolume, multisample analysis.

"Synergy H1 provides robust performance and for the first time makes "Hybrid Technology” available to life science, academic, and small biotechnology companies at a very competitive price,” said Gary Barush, director of marketing and sales at BioTek. "The modular architecture means that customers can easily upgrade from a monochromator-based multimode reader to a hybrid reader offering true versatility and unlimited assay use.”

Related Links:
BioTek Instruments, Inc.



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.